{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:04:08Z","timestamp":1790337848093,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00405-026-10375-w","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T01:30:10Z","timestamp":1781487010000},"page":"5949-5957","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of cytological subcategorization in indeterminate thyroid nodules: Optimizing management strategies by refining malignancy risk stratification"],"prefix":"10.1007","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5898-0506","authenticated-orcid":false,"given":"Stavroula","family":"Mouratidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Yanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleix","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asit","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Jeannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina T.","family":"Munonyara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Malhorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul V.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Simo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"10375_CR1","doi-asserted-by":"publisher","unstructured":"Durante C, Hegedus L, Czarniecka A, Paschke R, Russ G, Schmitt F et al (2023) 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management. Eur Thyroid J 12(5). https:\/\/doi.org\/10.1530\/ETJ-23-0067","DOI":"10.1530\/ETJ-23-0067"},{"issue":"9","key":"10375_CR2","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1089\/thy.2023.0141","volume":"33","author":"SZ Ali","year":"2023","unstructured":"Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA (2023) The 2023 Bethesda System for Reporting Thyroid Cytopathology. Thyroid 33(9):1039\u20131044. https:\/\/doi.org\/10.1089\/thy.2023.0141","journal-title":"Thyroid"},{"issue":"1","key":"10375_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/lary.29778","volume":"132","author":"P Staibano","year":"2022","unstructured":"Staibano P, Forner D, Noel CW, Zhang H, Gupta M, Monteiro E et al (2022) Ultrasonography and Fine-Needle Aspiration in Indeterminate Thyroid Nodules: A Systematic Review of Diagnostic Test Accuracy. Laryngoscope 132(1):242\u2013251. https:\/\/doi.org\/10.1002\/lary.29778","journal-title":"Laryngoscope"},{"issue":"2","key":"10375_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/jmp2020014","volume":"2","author":"M Nishino","year":"2021","unstructured":"Nishino M, Bellevicine C, Baloch Z (2021) Molecular Tests for Risk-Stratifying Cytologically Indeterminate Thyroid Nodules: An Overview of Commercially Available Testing Platforms in the United States. J Mol Pathol 2(2):135\u2013146. https:\/\/doi.org\/10.3390\/jmp2020014","journal-title":"J Mol Pathol"},{"issue":"5","key":"10375_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/cncy.22684","volume":"131","author":"EA Hall","year":"2023","unstructured":"Hall EA, Hartzband P, VanderLaan PA, Nishino M (2023) Risk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: Implications for molecular testing and surveillance. Cancer Cytopathol 131(5):313\u2013324. https:\/\/doi.org\/10.1002\/cncy.22684","journal-title":"Cancer Cytopathol"},{"issue":"4","key":"10375_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/cncy.21823","volume":"125","author":"TR Gan","year":"2017","unstructured":"Gan TR, Nga ME, Lum JH, Wong WM, Tan WB, Parameswaran R et al (2017) Thyroid cytology-nuclear versus architectural atypia within the Atypia of undetermined significance\/follicular lesion of undetermined significance Bethesda category have significantly different rates of malignancy. Cancer Cytopathol 125(4):245\u2013256. https:\/\/doi.org\/10.1002\/cncy.21823","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10375_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/cyt.12910","volume":"32","author":"C van der Horst","year":"2021","unstructured":"van der Horst C, Wright S, Young D, Tailor H, Clark L (2021) What is Thy3a? A study of 336 Thy3a (AUS\/FLUS) thyroid FNAs with histology compares UK RCPath with other reporting systems and shows how Thy3a subclassification can improve risk stratification and help address overuse of this category. Cytopathology 32(1):29\u201336. https:\/\/doi.org\/10.1111\/cyt.12910","journal-title":"Cytopathology"},{"issue":"7","key":"10375_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/cncy.21411","volume":"122","author":"HJ Park","year":"2014","unstructured":"Park HJ, Moon JH, Yom CK, Kim KH, Choi JY, Choi SI et al (2014) Thyroid atypia of undetermined significance with nuclear atypia has high rates of malignancy and BRAF mutation. Cancer Cytopathol 122(7):512\u2013520. https:\/\/doi.org\/10.1002\/cncy.21411","journal-title":"Cancer Cytopathol"},{"issue":"2","key":"10375_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/thy.2017.0419","volume":"28","author":"P Valderrabano","year":"2018","unstructured":"Valderrabano P, Khazai L, Thompson ZJ, Sharpe SC, Tarasova VD, Otto KJ et al (2018) Cancer Risk Associated with Nuclear Atypia in Cytologically Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis. Thyroid 28(2):210\u2013219. https:\/\/doi.org\/10.1089\/thy.2017.0419","journal-title":"Thyroid"},{"key":"10375_CR10","unstructured":"Cross P, Chandra A, Giles T, Johnson S-J, Poller D (2024) Guidance on the reporting of thyroid cytology specimen. RCPath. RCPath"},{"key":"10375_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cen.12515","volume":"81","author":"PBK Perros","year":"2014","unstructured":"Perros PBK, Colley S et al (2014) British Thyroid Association. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf) 81:1\u2013122. https:\/\/doi.org\/10.1111\/cen.12515","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10375_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1):1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"issue":"4","key":"10375_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jasc.2025.04.003","volume":"14","author":"CF Connelly","year":"2025","unstructured":"Connelly CF, Smithgall MC, Desai N, Cimic A, Baskota SU (2025) Performance characteristics of ThyroSeq, ThyGeNEXT\/ThyraMIR, and Afirma molecular platforms in evaluation of 1252 cytologically-indeterminate thyroid nodules. J Am Soc Cytopathol 14(4):243\u2013254. https:\/\/doi.org\/10.1016\/j.jasc.2025.04.003","journal-title":"J Am Soc Cytopathol"},{"issue":"1","key":"10375_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12022-024-09797-1","volume":"35","author":"M Bagis","year":"2024","unstructured":"Bagis M, Can N, Sut N, Tastekin E, Erdogan EG, Bulbul BY et al (2024) A Comprehensive Approach to the Thyroid Bethesda Category III (AUS) in the Transition Zone Between 2nd Edition and 3rd Edition of The Bethesda System for Reporting Thyroid Cytopathology: Subcategorization, Nuclear Scoring, and More. Endocr Pathol 35(1):51\u201376. https:\/\/doi.org\/10.1007\/s12022-024-09797-1","journal-title":"Endocr Pathol"},{"issue":"3","key":"10375_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/thy.2024.0455","volume":"35","author":"S Nachum","year":"2025","unstructured":"Nachum S, Tondi Resta I, Baloch Z, Mandel SJ (2025) Thyroid Nodules with Indeterminate Cytology and Negative Molecular Profile: Prevalence of Malignancy and Practice Paradigms for Surveillance. Thyroid 35(3):265\u2013273. https:\/\/doi.org\/10.1089\/thy.2024.0455","journal-title":"Thyroid"},{"issue":"4","key":"10375_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1089\/thy.2017.0274","volume":"28","author":"JXY Lim","year":"2018","unstructured":"Lim JXY, Nga ME, Chan DKH, Tan WB, Parameswaran R, Ngiam KY (2018) Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk. Thyroid 28(4):511\u2013521. https:\/\/doi.org\/10.1089\/thy.2017.0274","journal-title":"Thyroid"},{"issue":"8","key":"10375_CR17","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1002\/hed.24768","volume":"39","author":"SH Ahn","year":"2017","unstructured":"Ahn SH, Kim SD, Jeong WJ (2017) Comparison of risk of malignancy in a subgroup with atypia of undetermined significance\/follicular lesion of undetermined significance: A meta-analysis. Head Neck 39(8):1699\u20131710. https:\/\/doi.org\/10.1002\/hed.24768","journal-title":"Head Neck"},{"issue":"1","key":"10375_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12957-025-04095-4","volume":"23","author":"F Zhang","year":"2025","unstructured":"Zhang F, Mei F, Chen W (2025) Development of a malignancy risk prediction model combining ultrasound and cytology for Bethesda category III thyroid nodules. World J Surg Oncol 23(1):438. https:\/\/doi.org\/10.1186\/s12957-025-04095-4","journal-title":"World J Surg Oncol"},{"issue":"4","key":"10375_CR19","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/ohn.1360","volume":"173","author":"H Li","year":"2025","unstructured":"Li H, Lee CCY, Khoo HW, Bundele MM, Gan JYJ, Fu EWZ et al (2025) Refining the Management of Bethesda III Thyroid Nodules by Combining Nuclear Atypia with Sonographic Suspicion. Otolaryngol Head Neck Surg 173(4):848\u2013858. https:\/\/doi.org\/10.1002\/ohn.1360","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10375-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10375-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10375-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:50:10Z","timestamp":1790337010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-026-10375-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10375"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10375-w","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board (\u00abGuy\u2019s Cancer Cohort Access Committee and Steering Committee\u00bb, REC Reference: 23\/NW\/0105 IRAS Project ID: 325735) on April 8th, 2025.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a retrospective study approved by our hospital\u2019s Ethics Committee as above, with the need for written informed consent waived. All patient information was de-identified and patient consent was not required. Patient data will not be shared with third parties.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no competing interests with respect to the research, authorship, and\/or publication of this article.","order":4,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}